Fig. 6: Effects of chemotherapy on ACBP/DBI levels in breast cancer patients. | Cell Death & Disease

Fig. 6: Effects of chemotherapy on ACBP/DBI levels in breast cancer patients.

From: Effects of acyl-coenzyme A binding protein (ACBP)/diazepam-binding inhibitor (DBI) on body mass index

Fig. 6

Chemotherapy does not induce any change in BMI (A), but induces a decrease of ACBP/DBI (B), as well as a loss of the correlation between ACBP/DBI and BMI (C). ACBP/DBI better correlates with BMI after chemotherapy compared to before chemotherapy (D) and patients whose weight increased during chemotherapy tend to have higher DBI levels (E). Box and whisker plots representing BMI (kg/m2) (A) and ACBP/DBI levels (ng/mL) (B) before and after chemotherapy in the CANTO cohort. Scatter plots with regression lines between ACBP/DBI (ng/mL) and body mass index (kg/m2) are shown before and after chemotherapy for the CANTO cohort (C). Pearson’s correlation coefficient (R) and their p value and number of samples available (n) are shown in the legend of each panel.

Back to article page